about
Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWFLow-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibilityGenome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2.Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular diseaseGenome-wide association analysis of self-reported events in 6135 individuals and 252 827 controls identifies 8 loci associated with thrombosisGenome-wide association study for circulating levels of PAI-1 provides novel insights into its regulationComparison of HapMap and 1000 Genomes Reference Panels in a Large-Scale Genome-Wide Association Study.Sequence variation and genetic evolution at the human F12 locus: mapping quantitative trait nucleotides that influence FXII plasma levels.Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) ConsortiumCombined cis-regulator elements as important mechanism affecting FXII plasma levelsCommon genetic determinants of lung function, subclinical atherosclerosis and risk of coronary artery diseaseHuman genetic evidence for involvement of CD137 in atherosclerosis.Genetic variants from lipid-related pathways and risk for incident myocardial infarctionNo evidence for genome-wide interactions on plasma fibrinogen by smoking, alcohol consumption and body mass index: results from meta-analyses of 80,607 subjects.Sex-Specific Effects of Adiponectin on Carotid Intima-Media Thickness and Incident Cardiovascular DiseaseA meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration.A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistanceA genome-wide exploration suggests an oligogenic model of inheritance for the TAFI activity and its antigen levelsDiscovery and refinement of genetic loci associated with cardiometabolic risk using dense imputation maps.Genome-wide association study with additional genetic and post-transcriptional analyses reveals novel regulators of plasma factor XI levels.Analysis with the exome array identifies multiple new independent variants in lipid lociGenetic determinants of plasma β₂-glycoprotein I levels: a genome-wide association study in extended pedigrees from Spain.Identification of the BCAR1-CFDP1-TMEM170A locus as a determinant of carotid intima-media thickness and coronary artery disease risk.Influence of coronary artery disease-associated genetic variants on risk of venous thromboembolism.Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism.The F7 gene and clotting factor VII levels: dissection of a human quantitative trait locus. 2005.Phenotypic Modulation of Smooth Muscle Cells in Atherosclerosis Is Associated With Downregulation of LMOD1, SYNPO2, PDLIM7, PLN, and SYNM.SNP sets selection under mutual information criterion, application to F7/FVII dataset.The F7 gene and clotting factor VII levels: dissection of a human quantitative trait locus.Human F7 sequence is split into three deep clades that are related to FVII plasma levels.Complexity of the genetic contribution to factor VII deficiency in two Spanish families: clinical and biological implications.Predicting venous thrombosis in women using a combination of genetic markers and clinical risk factorsA Genome-Wide Association Study Identifies KNG1 as a Genetic Determinant of Plasma Factor XI Level and Activated Partial Thromboplastin TimeLack of association of non-synonymous FUT2 and ALPL polymorphisms with venous thrombosisGenetically Determined FXI (Factor XI) Levels and Risk of StrokeClustering of individuals given SNPs similarity based on normalized mutual information: F7 SNPs in the GAIT sampleAuthor Correction: Discovery and refinement of genetic loci associated with cardiometabolic risk using dense imputation mapsGenome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex DisordersGenome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels
P50
Q28607764-C1220343-11F6-432A-B2A0-D5BE54C42C8CQ28651068-EAB4A077-5D32-47DD-9D0C-70F3F818DE6CQ28658007-BA782BC8-00BE-446C-9B4E-9EC75B4C702FQ28661433-8AB670C5-E2C1-47E4-9344-488DE38D9934Q28661433-CB48122C-41C3-4F36-A33D-5ABBABC5C42AQ30277281-614A1DD2-7F40-45D9-9C4D-36D7409F3F58Q30415902-49B63899-3884-4883-8D66-269F268CE641Q30490746-A83F32B3-C419-41BE-89AF-407CBAB89CB2Q33559782-BAFE129A-91E0-4413-A792-90F674CAB81CQ33570959-4CBD5444-647A-438A-9BBE-0FCCA7462D83Q33817075-7F4C82F9-2187-4AB9-8713-1D0F9186B9A9Q34003352-94B3D076-A1E0-49D1-9A2D-8F20B14FC851Q34004971-457FC2EC-4DCD-407B-9259-8D30E65A043BQ34004971-5C213FCF-BF7F-4AB2-804E-CD7EF4863EC0Q34416210-440D3EF1-8ED3-488C-9DC1-231B97FFCCACQ34653929-5AA8C51A-2545-4776-823B-433A34EAA7F5Q34796836-65352306-60DB-4F0E-A650-CBE84819DBE3Q36141562-7F4733E9-D28B-492D-8F4B-AD31A3695F39Q36468916-6C900AD9-3F02-4E35-8551-98F424F9D52AQ36731268-94FBE5C5-6951-4008-B074-689B4C33E88BQ36992117-6E3B4E7C-E816-44CA-8450-C4CAE0A56AB8Q37613798-1A12F336-CC42-4E5D-BB17-9F359FB9BC99Q37613798-7D6AAE6E-80F1-4009-985C-B17657C1D5DFQ39040002-C2C3BF50-450B-4B1F-8213-E541C0B1D9DDQ41731666-DACA1150-C13D-4451-B99D-7A444867B07CQ43526508-BA12B94F-E3ED-4210-85C1-2D992995AF18Q46376919-61378A54-FF9D-41D9-AAB6-56DF9DD387BFQ48310876-36BA5890-0622-4777-B1F1-3C434CCC56EFQ48407473-22C9FEC4-1A45-41C9-86C8-FA5D92D487DCQ48463468-CD87180C-2F8F-4056-844A-5F7CED28460FQ51608485-6FF177F3-6237-4809-B6A5-5FA15BF32CAEQ51854591-5EDF7DEC-6F90-49EF-B75B-EDB7A3C11E38Q51944590-E1F6AF3C-8A55-4FAC-9E2E-CC00076ACDD8Q52841164-7CA26619-B250-4F71-8E3A-A97ABE0D5214Q54650864-F7AF06E7-244B-4449-9E03-5CF2CA0F6C67Q57303396-24BDAC0F-00A6-47BF-BFE2-896B9A533815Q57315828-F6D5642A-B1B4-44A9-9BDE-B9E3CE1FF1E4Q57605671-ED2322F1-AFFC-46BB-9723-07B1C0AA1803Q57789163-7BAE9F18-799F-46D1-A134-8E3095179331Q58611808-681AA237-2123-43A6-BA8C-4CE918E37102
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Maria Sabater-Lleal
@ast
Maria Sabater-Lleal
@en
Maria Sabater-Lleal
@es
Maria Sabater-Lleal
@nl
Maria Sabater-Lleal
@sl
type
label
Maria Sabater-Lleal
@ast
Maria Sabater-Lleal
@en
Maria Sabater-Lleal
@es
Maria Sabater-Lleal
@nl
Maria Sabater-Lleal
@sl
prefLabel
Maria Sabater-Lleal
@ast
Maria Sabater-Lleal
@en
Maria Sabater-Lleal
@es
Maria Sabater-Lleal
@nl
Maria Sabater-Lleal
@sl
P108
P106
P21
P214
1971156075617453980007
P31
P496
0000-0002-0128-379X
P735
P7859
viaf-1971156075617453980007